Skip to main content

Table 3 Before and after VD supplementation anthropometric and laboratory data of the supplemented patients (obese/non-obese) (results presented as mean ± SD)

From: Lipid profile of childhood cancer survivors and the effects of vitamin D supplementation: a prospective study

  Obese patients Non-obese patients
Before VD supplementation (N = 17) After VD supplementation (N = 15) Before VD supplementation (N = 20) After VD supplementation (N = 20)
BMI 29.4 ± 3.27 27.35 ± 1.5 18.2 ± 1.1 18.6 ± 2.4
BMI-Z score 2.24 ± 0.42 2.11 ± 0.22 0.42 ± 0.74 0.43 ± 0.62
Calcium (mg/dl) 9.9 ± 0.5 9.6 ± 0.5 9.7 ± 0.5 9.6 ± 0.3
Phosphorus (mg/dl) 5.2 ± 1.3 5.4 ± 0.5 5.4 ± 0.1 5.3 ± 0.4
Magnesium (mg/dl) 2.31 ± 0.25 2.32 ± 0.35 2.32 ± 0.31 2.38 ± 0.22
PTH (pg/ml) 44.7 ± 10.7 43.2 ± 9.9 44.2 ± 8.9 34.3 ± 14.2** (P = 0.0119)
25OH-VD (ng/ml) 13.30 ± 5.67 18.73 ± 6.61* (P = 0.018) 15.36 ± 5.73 26.74 ± 4.48** (P < 0.0001)
TC (mg/dl) 182.6 ± 22.3 162.3 ± 21.1* (P = 0.013) 172.4 ± 20.2 161.4 ± 24.2
TG (mg/dl) 88.7 ± 45.2 86.6 ± 34.1 86.0 ± 25.7 83.0 ± 29.3
HDL-C (mg/dl) 42.5 ± 12.6 43.4 ± 10.7 44.5 ± 17.2 42.5 ± 11.3
LDL-C (mg/dl) 109.8 ± 26.8 94.8 ± 20.6* (P = 0.049) 92.3 ± 21.7 90.5 ± 25.3
  1. BMI body mass index, PTH parathyroid hormone, 25OH-VD 25-hydroxyvitamin D, TC total cholesterol, TG triglycerides, LDL-C low-density lipoprotein-cholesterol, HDL-C high-density lipoprotein-cholesterol
  2. *P ≤ 0.05 of significance (obese before and after VD supplementation)
  3. **P ≤ 0.05 of significance (obese after VD supplementation versus non-obese patients after VD supplementation)